Loading patent…
AssigneesInternational AIDS Vaccine Initiative, The Scripps Research Institute, Cornell Center for Technology, Enterprise & Commercialization
InventorsMichael Caulfield, Albert Cupo, Hansi Dean, Simon Hoffenberg, C. Richter King, P. J. Klasse, Andre Marozsan, John P. Moore, Rogier W. Sanders, Andrew Ward, Ian Wilson, Jean-Philippe Julien
Estimating the term…
The present application relates to novel HIV-1 envelope glycoproteins, which may be utilized as HIV-1 vaccine immunogens, and antigens for crystallization, electron micrsocopy and other biophysical, biochemical and immunological studies for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions, which are formulated into the vaccines of the present invention.
An engineered or non-naturally occurring HIV-1 envelope glycoprotein isolated from a BG505 virus and having a SOSIP mutation.
Dependencies are inferred from the claim text.